Dissecting tumor lymphocyte infiltration to predict benefit from immune-checkpoint inhibitors in metastatic colorectal cancer: lessons from the AtezoT RIBE study - Moretto, R; Rossini, D; Catteau, A (J Immunother Cancer, 2023)
et al.